Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cornerstone Specialty Network aggregates independent community-based oncology practices into the largest such network in the U.S., providing value-added services including group purchasing power for specialty drugs/biologics, educational resources for providers and patients, real-world data collection programs ("Practice Patterns"), market research capabilities for life science companies (advisory boards/focus groups/surveys), clinical benchmarking tools for members, and support to maintain independence of local cancer centers. In April 2024 it merged with Altus Biologics, Remedy GPO and Health Coalition Inc. to form Provider Network Holdings under Waud Capital Partners ownership. It does not itself run drug development programs or clinical trials as a sponsor.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cornerstone Specialty Network.